{
    "organizations": [],
    "uuid": "85934c4846243563e1c77ae293f66da00b17bea9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-agios-qtrly-loss-per-share-163/brief-agios-qtrly-loss-per-share-1-63-idUSASC09ZVU",
    "ord_in_thread": 0,
    "title": "BRIEF-Agios Qtrly Loss Per Share $1.63",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 4 (Reuters) - Agios Pharmaceuticals Inc:\n* AGIOS PROVIDES BUSINESS UPDATE ON DISCOVERY RESEARCH STRATEGY AND PIPELINE, PROGRESS ON CLINICAL PROGRAMS, COMMERCIAL LAUNCH PREPARATIONS AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AT INVESTOR DAY\n* Q1 REVENUE $8.8 MILLION VERSUS I/B/E/S VIEW $10.6 MILLION\n* AGIOS PHARMA-SEES ENOUGH CASH,CASH EQUIVALENTS,MARKETABLE SECURITIES AS OF MARCH 31,AMONG OTHERS,TO FUND OPERATING EXPENSES,CAPEX THROUGH AT LEAST 2022 END\n* QTRLY LOSS PER SHARE $1.63 * Q1 EARNINGS PER SHARE VIEW $-1.63 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-04T19:23:00.000+03:00",
    "crawled": "2018-05-05T12:04:25.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "agio",
        "pharmaceutical",
        "inc",
        "agio",
        "provides",
        "business",
        "update",
        "discovery",
        "research",
        "strategy",
        "pipeline",
        "progress",
        "clinical",
        "program",
        "commercial",
        "launch",
        "preparation",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "investor",
        "day",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "agio",
        "enough",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "march",
        "among",
        "others",
        "fund",
        "operating",
        "expense",
        "capex",
        "least",
        "end",
        "qtrly",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}